NCT00003434View on ClinicalTrials.gov

Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer

PHASE1TerminatedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

June 30, 1998

Primary Completion Date

August 31, 2002

Study Completion Date

August 31, 2002

Conditions

Pancreatic Cancer

Interventions

BIOLOGICAL

carcinoembryonic antigen peptide 1

BIOLOGICAL

hepatitis B antigen peptide

Trial Locations (1)

27710

Duke Comprehensive Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER